List of countries by prevalence of opiates use

From WikiMD's WELLNESSPEDIA

List of countries by prevalence of opiates use refers to the statistical data that ranks countries based on the percentage of their population that has reported using opiates in the past year. Opiates, a category of narcotic drugs, include substances such as heroin, morphine, and codeine. The use of these substances can lead to addiction, overdose, and other serious health issues.

Prevalence of Opiates Use[edit]

The prevalence of opiates use varies greatly from country to country. Factors influencing this variation include cultural attitudes towards drug use, the availability of drugs, and the effectiveness of law enforcement and drug prevention programs.

Data Collection[edit]

Data on the prevalence of opiates use is collected through surveys, hospital records, and law enforcement data. The United Nations Office on Drugs and Crime (UNODC) is a primary source of international data on drug use.

Top Countries by Prevalence of Opiates Use[edit]

As of the most recent data, the countries with the highest prevalence of opiates use are:

  1. Afghanistan
  2. Iran
  3. Russia

These countries have a high prevalence of opiates use due to a combination of factors including the availability of opiates, social and economic conditions, and the effectiveness of drug prevention and treatment programs.

See Also[edit]

References[edit]







This article is a stub related to pharmacology. You can help WikiMD by expanding it!


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.